These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18173614)

  • 21. [Exanthema in a patient infected with the human immunodeficiency virus after starting antiretroviral treatment].
    Palacios Muñoz R; Santos González J; Bosch García R; Márquez Solero M
    Rev Clin Esp; 2000 Nov; 200(11):635-6. PubMed ID: 11196597
    [No Abstract]   [Full Text] [Related]  

  • 22. Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.
    Tebruegge M; Ritz N; Connell T; Curtis N
    Pediatr Infect Dis J; 2008 Nov; 27(11):1041-2. PubMed ID: 18833024
    [No Abstract]   [Full Text] [Related]  

  • 23. Photosensitivity reactions.
    Shuster J
    Nursing; 1996 Jul; 26(7):24. PubMed ID: 8717755
    [No Abstract]   [Full Text] [Related]  

  • 24. First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.
    van Vonderen MG; Lips P; van Agtmael MA; Hassink EA; Brinkman K; Geerlings SE; Sutinen J; Ristola M; Danner SA; Reiss P
    AIDS; 2009 Jul; 23(11):1367-76. PubMed ID: 19424051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nevirapine and/or co-trimoxazole induced Stevens Johnson syndrome in HIV infected patient--a case report.
    Patel K; Panchasara A; Purohit B; Tripathi CB
    Curr Drug Saf; 2013 Feb; 8(1):72-4. PubMed ID: 23656450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal outcome of nevirapine-associated toxic epidermal necrolysis.
    Leng K; Lonsdorf A; Hartmann M
    Int J STD AIDS; 2008 Sep; 19(9):642-3. PubMed ID: 18725560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactic acidosis in HIV infected children due to antiretroviral therapy.
    Shah I
    Indian Pediatr; 2005 Oct; 42(10):1051-2. PubMed ID: 16269849
    [No Abstract]   [Full Text] [Related]  

  • 28. Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.
    Mason AR; Cortes GY; Pollack RB
    Pediatr Dermatol; 2008; 25(1):128-9. PubMed ID: 18304177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 30. Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
    Gutiérrez S; Guillemi S; Jahnke N; Montessori V; Harrigan PR; Montaner JS
    Clin Infect Dis; 2008 Feb; 46(3):e28-30. PubMed ID: 18181733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trimethoprim-sulfamethoxazole--induced methemoglobinemia in an HIV-infected patient.
    Koirala J
    Mayo Clin Proc; 2004 Jun; 79(6):829-30. PubMed ID: 15182104
    [No Abstract]   [Full Text] [Related]  

  • 32. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T; Rao Thudi N; Koundinya Tippabhotla S; Khuroo A; Marwah A; Kumar Shrivastav V; Tandon M; Raghuvanshi R; Biswal S
    Clin Ther; 2007 Dec; 29(12):2677-84. PubMed ID: 18201583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational models of antiviral toxicity.
    Samuels DC
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):43-8. PubMed ID: 17265740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
    Rey D; Hoen B; Chavanet P; Schmitt MP; Hoizey G; Meyer P; Peytavin G; Spire B; Allavena C; Diemer M; May T; Schmit JL; Duong M; Calvez V; Lang JM
    J Antimicrob Chemother; 2009 Feb; 63(2):380-8. PubMed ID: 19036752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous and arterial blood lactate in HIV-infected patients.
    Zala C; Harris M; Ochoa C; Tocci M; Quercia R; Mittelman G; Perez H; Cahn P; Montaner JS
    Antivir Ther; 2002 Dec; 7(4):309-10. PubMed ID: 12553487
    [No Abstract]   [Full Text] [Related]  

  • 36. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
    Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
    AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
    [No Abstract]   [Full Text] [Related]  

  • 37. Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates.
    Schmitz T; Weizsaecker K; Feiterna-Sperling C; Eilers E; Obladen M
    AIDS; 2006 Apr; 20(7):1082-3. PubMed ID: 16603869
    [No Abstract]   [Full Text] [Related]  

  • 38. Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization.
    Kardaun SH; de Waard MM; de Monchy JG
    Contact Dermatitis; 2009 Jul; 61(1):50-1. PubMed ID: 19659967
    [No Abstract]   [Full Text] [Related]  

  • 39. Comment on: High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
    Parienti JJ
    J Antimicrob Chemother; 2009 May; 63(5):1080; author reply 1080-1. PubMed ID: 19158108
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
    Redfield RR; Morrow JS
    Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.